During the Lightning Round segment of Monday's Mad Money program, one caller asked Jim Cramer about Johnson & Johnson (JNJ) : "This stock has a big development pipeline and that's why it keeps going up," he replied.
More from Investing
If I'm going to speculate anywhere, it might be in the iShares Nasdaq Biotechnology ETF. Here's why.
It isn't a coincidence that the copper market is teetering between feast or famine at the same time as the S&P 500.
If you knew where to look, you could find some hot pockets of good trading.
My reading of the technicals and Cramer's advice don't always agree. Here's where you can choose when to pull the lever on SOFI.